tirzepatide pancreatitis warning Can Cause Pancreatitis? What To Know People using GLP-1 weight-loss injections

13.7% | Eli Lilly and Company, accessed April 23, 2025, How to Use, Dosing & Side Effects | Mounjaro (tirzepatide) - Eli Lilly, accessed April 23, 2025, Mounjaro (tirzepatide) Injection: The First and Only GIP and GLP-1 Receptor Agonist Approved for Type 2 Diabetes | Eli Lilly and Company, accessed April 23, 2025, Lilly's SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between 16.0% and 22.5% weight loss in adults with obesity or overweight, accessed April 23, 2025, Why you're not losing weight on Zepbound

Combined with the physiological stress of weight loss, it creates a compounding effect

This slow increase helps reduce side effects

Not appropriate for people with any of the following: Your provider will review your history and labs and discuss alternatives if semaglutide is not a fit

Not everyone needs this dose